Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda

NCT01578447 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
356
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators